Final answer:
The statement is true if the National Medicines System's responsibilities include integrity and Drug Utilization Review checks, as these are important aspects of medication management and safety.
Step-by-step explanation:
The statement that the National Medicines System (NMS) will perform integrity checks and Drug Utilization Review (DUR) checks can be true depending on the specific functions and regulations of the country's NMS in question. Generally, a National Medicines System can be responsible for various aspects of medication management, including assessing the safety, efficacy, and quality of medicines, as well as monitoring their use. Integrity checks may involve ensuring the authenticity and proper sourcing of medicines, while Drug Utilization Review is a process that helps to ensure that drugs are used appropriately, safely, and effectively.
The DUR involves assessing prescription drug prescriptions and usage at individual and population levels to improve medication use and outcomes. It typically includes reviewing past patterns of medication use, looking for issues such as duplications, interactions, dosage errors, and other potential concerns that could compromise patient care. Therefore, if the role of the NMS includes overseeing the pharmaceutical sector and monitoring drug use, the statement can indeed be correct.